4-(quinoline-8-sulfonamido)benzoic acid, 95.0%, 500mg

4-BROMO-2-METHOXY-5-NITROANILINE, 95.0%, 10g

OCTADECAMETHYLOCTASILOXANE, 95%, 250mg

2-(4-((TERT-BUTOXYCARBONYL)AMINO)TETRAHYDRO-2H-PYRAN-4-YL)ACETIC ACID, 95.0%, 1g

4-Amino-p-terphenyl>97.0%(GC)25g

1-Amino-4-hydroxyanthracene-9,10-dione, 97.0%, 25g

methyl 2-(methylthio)benzoate, 98%, 10g

Molecular sieve 3, powder, 30 µm, 250 g, glass packaging

(2R,3S,4S,5R)-2-(6-Amino-2-fluoro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol, 95.0%, 25g

1-(tert-Butoxycarbonyl)-3,3-difluoro-4,4-dihydroxypiperidine>97.0%(GC)100mg

9-Chlorononan-1-ol, 95.0%, 1g

Glass syringe Dosys with Luer connection (glass), 1 ml, 3 pieces

2-((2-Chlorobenzyl)amino)butan-1-ol, 95%, 1g